HeiQ, a leader in materials innovation, is transitioning to private ownership following its delisting from the London Stock Exchange yesterday. The decision underscores the company’s strategic evolution and is supported by major anchor investors.

Returning to private ownership is an important step in the company’s evolution, enabling HeiQ to fund and scale its portfolio of breakthrough technologies, including HeiQ Synbio, HeiQ AeoniQ, HeiQ GrapheneX, and HeiQ Xpectra going forward, HeiQ shares will remain available for trading on the Asset Match platform. Current and prospect shareholders are invited to visit Asset Match's HeiQ page for trading updates and auction information.

Strong shareholder support

HeiQ’s strategic transition is supported by anchor investor Darren Morcombe, a long-time believer in HeiQ’s innovation capabilities and financial potential. Darren recently increased his stake to approximately 22%, making him HeiQ’s largest individual shareholder. Known for his hands-on investment approach, Darren personally tries out a company’s products before committing. His belief in HeiQ has not wavered over the years, as he continues to experience and endorse HeiQ-powered innovations.

“I am pleased to support HeiQ’s transformation as it strengthens its position as a technology incubator for high-growth ventures. My increased investment underlines my confidence in HeiQ’s robust innovation pipeline and its focus on sustainable growth,” said Darren Morcombe, Executive Chairman and Founder of Springtide Capital. “I look forward to supporting the company’s journey in delivering game-changing solutions that will impact markets globally.”

Carlo Centonze, CEO & Co-Founder of HeiQ and the second largest shareholder (~19%), highlighted the opportunities this transition offers: “Returning to private ownership allows HeiQ to focus on both strengthening our well-established core businesses in textiles, flooring, industrial, and antimicrobial specialties, and driving the value creation of our breakthrough technologies. Our ventures – HeiQ Synbio, HeiQ AeoniQ, HeiQ GrapheneX, and HeiQ Xpectra – are designed to address pressing global challenges in sustainability, health, and materials innovation. With a strong foundation in our traditional markets and unwavering commitment from key shareholders, we are well-positioned for sustainable growth and value creation.”

HeiQ’s private structure, alongside the planned growth capital raise in December 2024, will enable a more agile approach to scaling its breakthrough technologies in textiles, sustainable materials, and cutting-edge synbiotics for cleaning and personal care.

www.heiq.com